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Adolescent girls and young women who are at risk for unplanned pregnancy and sexually transmitted infection (STI), including
HIV, are frequently counseled to use a hormonal contraceptive to protect against the former and condoms to protect against the
latter,forexampe,AmericanCollegeofObstetriciansandGynecologists,2011.Thepresentpaperreviewstheliteratureonmultiple
risk messages, compliance with this dual-use recommendation, predictors of dual use, and interventions developed to encourage
dual use. Data indicate that simultaneous use of these two methods is not common, and that eﬀorts to encourage dual use have
not yielded promising results. An alternative is to recommend condom use alone, since condoms protect very well against STI
and HIV, and quite well against pregnancy when used consistently and correctly. The availability of emergency contraception is
relevant here. Research utilizing a randomized controlled trial is recommended.
1.Introduction:WhyRecommendDual
Protection during Sex?
Unprotectedsexcanhavenumerousconsequences,including
unintended pregnancy and sexually transmitted infections
(STI). Among US teens and young women, both are all
too common and occur disproportionately within the same
population: low-income women of color, especially African
American women. In 2009, 410,000 teens aged 15–19 gave
birth in the United States [1]. It is estimated that half of
all pregnancies are unintended, and the ﬁgure is higher—
62%—among women with incomes below the poverty level
[2]. Poverty is also a risk factor for HIV/AIDS and other STIs
[3, 4]. HIV incidence among those aged 13–29 is estimated
to be 27% of the total 21,000 cases per year [5]. Data
from the National Health and Nutrition Examination Survey
(NHANES) indicated that, among sexually experienced girls
aged 14–19, 38% had at least one of ﬁve STIs [6] .Th era t ef o r
African American girls was 44%. It is critical that everything
possiblebedonetoreducetheprevalencebothofunintended
pregnancy and STI, the greatest risk for which is largely
present among the same young women.
Hormonal contraceptives (HCs), which are highly eﬀec-
tive at preventing pregnancy, do not prevent STI, including
Human Immunodeﬁciency Virus (HIV). On the other hand,
male condoms, if used correctly and consistently, greatly
reduce transmission of HIV [7]a n dS T I[ 8, 9]. In an eﬀort
to prevent both unintended pregnancy and STI, guidelines
for adolescents recommend encouraging the use of both
malecondomsandanothercontraceptive:“...sexuallyactive
adolescents should be encouraged to use condoms in con-
junction with a more eﬀective method of contraception to
provide both eﬀective pregnancy prevention and protection
against STIs” [10], although it is not known how compli-
ant health care providers are with this recommendation.
There are data to suggest that the use of some HCs may
potentiate the risk of HIV infection for purely biological
reasons, although study ﬁndings are inconsistent [11, 12].
On the other hand, condoms, which are highly eﬀective in
preventing sexually transmitted infection and transmission,
a r el e s se ﬀective than HCs in preventing pregnancy, both in
typical and perfect use. Because many adolescents and young
women are at risk for both unintended pregnancy and STI,
it is frequently recommended that such girls and women be
counseled to use two forms of protection, one to prevent
pregnancy and one to prevent STI [10, 13, 14].
To our knowledge, no published research has tested
directly how these two risk messages are processed or2 Infectious Diseases in Obstetrics and Gynecology
evaluated. A body of literature in social psychology, however,
has studied the eﬀects of multiple messages and found them
to be complex [15]. Indeed, individual diﬀerences in the
“need for cognition”—that is, tendency for and enjoyment
of thought—can aﬀect whether the second of two messages
is even cognitively processed [16].
2.What DoWe Know aboutMultiple
Risk Messages?
When measures are used to protect people from harm, some
recipients may increase the riskiness of their behavior in
other ways. For example, there is evidence that children
engage in more hazardous physical activity when wearing
safety gear [17]. This phenomenon is known as “risk
compensation”, a form of behavioral disinhibition that
has been theorized to be a product of “risk homeostasis”
[18]. In the area of HIV prevention, concern about risk
compensation in the form of reduced condom use (“condom
migration”) has been voiced in connection with preventive
vaccines, preexposure prophylaxis, and vaginal microbicides
[19, 20], all of which are assumed to provide only partial
protectionagainstHIVandallofwhich,atleastcurrently,are
recommended for use in conjunction with condoms. While
to date evidence for risk compensation in these contexts has
been mixed [21–26], concern remains high and the issue is
widely believed to be unresolved [27].
Also relevant to this issue is the possibility that reasoning
about dual-risk messages opens the door for post hoc
justiﬁcations for risky behavior. For example, Gold and
colleagues studied gay men who had engaged in risky sexual
behavior [28, 29]. In these studies, men justiﬁed their risk
behavior by reasoning such justiﬁcations as “AIDS is hard to
transmit”and“I’matlessriskthanmostguys.”Itmaybethat
justiﬁcations are used to avoid condom use when another
formofprotectionisinplaceandcanbeconsideredtoconfer
safety (e.g., a microbicide; hormonal contraception).
Another form of multiple messages, “hierarchical mes-
sages” combines diﬀerent HIV/STI risk reduction strategies
to be used, not concurrently, but rather singly, in descending
order of eﬃcacy [30]. For example, if abstinence is not
possible, use a male condom; if this is not possible, use
a female condom; and so on. While this approach has
diﬃculties, including the use of less eﬀective strategies
compared with single-method messages [31, 32], it is less
relevant to the present topic and will not be extensively
reviewed here.
3. How Often Are Dual-Methods
Recommendations Followed?
A review of the literature on dual methods was conducted
using the terms “dual method” and “dual protection” in
Medline (1996—present) and PsycInfo (1987—present).
Only studies conducted in the United States were used.
Studieshaveyieldedestimatesof3%to26%ofstudysamples
that report dual method use, for periods of time ranging
from last six to the previous six months [33–42]. It should
be noted, however, that the study obtaining the rate of
26% included HIV-positive women and all participants were
six months postpartum [23]. This study also distinguished
between alternating and simultaneous dual-method use, the
former describing use of diﬀerent methods at diﬀerent times
and the latter indicating use of both methods on every sexual
occasion. Of the women reporting dual use in this study,
only 64% reported simultaneous use. This ﬁnding suggests
that a sizeable proportion of women reporting dual use
in the studies just cited are in fact engaging in alternating
use, meaning that the rates of dual methods as intended are
overestimated by studies not making this distinction.
Dataoncontraceptiveandcondomusearereportedfrom
the Youth Risk Behavior Survey, a nationally representative
school-based health survey, by the Centers for Disease
Control and Prevention [43]. In 2009, use of dual methods
(a condom and an HC) at last intercourse was reported
by 13.1% of white girls, 53.6% of black girls, and 3.2% of
Hispanic girls. Condom use alone, however, was reported
by 42.5%, 45.1%, and 44.9% of these groups, respectively.
It should be noted that these respondents were aged 15–19,
and that condom use decreases with age [44]. In a study of
womenaged18–45,thepatternfordualusewasreversed:5%
of white women, 15% of African American women, and 16%
of Hispanic women were users of condoms in conjunction
with an eﬃcient method of birth control [39].
It should be noted that use of dual methods by women
appearstobeincreasing,atleastbetween1995and2002[45],
although this eﬀect is THE strongest for younger women
(aged 15–17) and drops oﬀ at age 18-19 [45]. This increase,
as well as a general increase in condom use and abstinence,
are thought to account for declines in teen pregnancy rates
[45].
3.1. Predictors of Dual Use. A number of factors have been
showntopredictdualmethodsuse.Onefactorislevelofrisk,
and here the news is unfortunate: those at higher risk are less
likelytousedualmethods.Inonestudy[33],womenwithsix
or more partners were less likely than those with fewer to use
methods preventing STI (i.e., condoms). Those with good
communication with parents [38, 46] ,w h o s es e x u a ld e b u t
was later [46], and who had fewer nonsexual risk behaviors
[46], have been found to be more likely to use dual methods.
On the other hand, another study found that women with
more than one sex partner were more likely to use dual
methods than any single method [35]. Younger women are
more likely to use dual methods than older women [35].
Thus, conﬂicting results have been obtained regarding this
issue.
Aspects of sexual relationships also inﬂuence contra-
ception and condom use. Those who report newer and
less committed sexual relationships [35, 37, 38, 42]a r e
more likely to be dual methods users than others. Similarly,
married or cohabiting women are less likely to use dual
methods (or condoms) [39, 42]. Conversely, women whose
communication with sex partners was good and who
expected good support from partners should they become
pregnant [42] were also likely to be dual method users. Also
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decision-making with their partners were more likely than
those who did not to use dual methods [39]. These correla-
tional data are diﬃcult to interpret; however, it may be that
women who are relatively empowered in their relationships
are able to use the methods that they choose.
Not surprisingly, the most robust predictors of dual
method use have to do with women’s primary concerns; that
is, avoiding pregnancy versus avoiding disease. In fact, in one
study, relationship status was signiﬁcant in bivariate analysis
but lost signiﬁcance when motives for use were entered into
the model [46]. Those reporting high levels of motivation
to avoid STI and HIV [32, 39] or perceive their partners
to possibly have HIV or STI [38] are also more likely to be
dual-method than HC-only users. In a study of adolescents,
however, desire to avoid pregnancy was associated with dual
method use, while concern about STI and HIV did not
[34]. It should be noted that this comparison was with the
combination of HC alone and condom use alone, and it
cannot be determined which of these subgroups may have
been responsible for the diﬀerence (i.e., HC and condom use
may have “cancelled each other out” in the analysis, while
condom use may, by itself, have been signiﬁcantly associated
with concern about STI and HIV). Finally, women who
express concern about both pregnancy and STI, or have had
an STI, or perceived that condoms were eﬀective against STI,
were more likely to use dual methods rather than a single
method [39].
In the afore-mentioned study that included HIV-infected
women, HIV positivity was a strong predictor of dual
method usage [41], indicating that women were strongly
motivated to prevent transmission of the virus to their part-
ners.Womeninthisstudy,whoweresixmonthspostpartum,
were also more likely to report dual method use if they
felt that having another pregnancy “would be upsetting” if
it occurred within the next six months. Additionally, dual
method use was signiﬁcantly predicted by having abstained
from alcohol during the postpartum period.
A study conducted in the Netherlands [36]u s e dh y p o -
thetical vignettes to assess behavioral intentions to use
condoms. In the vignettes, participants imagined that they
had just met someone that they were mutually attracted to
andwithwhomtheyhaddecidedtohavesex.Inonevignette,
it was stated that there would be no risk of pregnancy,
the other contained no such statement. Not surprisingly,
intention to have sex without a condom was three times as
high for the vignette in which pregnancy was not a concern
as for the other. In this study, each participant responded
to both vignettes, and the investigators compared condom
use intentions for those who changed from condom to
noncondomresponseswhentheonewithpregnancyconcern
preceded the other. Those who abandoned condom use
intentions diﬀered from the intentions of those who did not
in three ways: they had lower perceived seriousness of STI,
lower perceptions of friends’ perceived seriousness of STI,
and they reported lower perceived susceptibility to STI after
unprotected sex.
Thus, although studies have yielded some inconsistent
results, it appears that most women use a single method of
protection, and the method used is based on motivation to
prevent the outcome of greatest concern [47]. This is most
often concern about pregnancy, which is associated with
HC use; those concerned about STI are more likely to be
condom-only or dual-method users.
4. Condoms to PreventSTI andPregnancy:
How Effective Are They?
It is very clear that condoms are eﬀective against HIV [1]
and STI [9], when used correctly and consistently. It is also
the case that HCs have no appreciable eﬀect on preventing
STIs. But what about pregnancy? There is indeed evidence
that condoms as typically used are a less eﬀective means of
c o n t r a c e p t i o nt h a nH C[ 48]. Condoms, when used perfectly,
have a pregnancy rate of 2% and when used typically, it
is 17.4%. The pill, when used perfectly, has a pregnancy
rate of 0.3% and when used typically, it is 8.7%. However,
condoms are in fact superior to other commonly used
alternative forms. As typically used, condom failure rates
are on a par with those of diaphragms and the cervical
cap or sponge for nonparous women and are markedly
superior to withdrawal, spermicides, the female condom,
and the cervical cap or sponge for parous women [48].
Using data from the National Survey of Family Growth,
Pazol and colleagues [49]e s t i m a t e dt h a ti fh a l fo fa l lw o m e n
using HCs only also used condoms, approximately 40% of
unplanned pregnancies and abortions couldbe prevented. In
anycase,itisclearthatmanyteensdousecondoms,although
existing data cannot tell us with what consistency. Condom
use has been increasing in this age group, presumably in
response to HIV/STI prevention programs and is believed to
be responsible for decreases in teen pregnancy rates [1, 44].
To gauge the consistency with which condoms are used, it
is important to assess use speciﬁcally with diﬀerent partners
[50]; however, consistent use appears to be suboptimal. For
example, one study found that only 45% of condom-using
teenage boys used condoms with every act of sex [44].
The use of male condoms appears to be a viable option
for most women. On the other hand, achieving correct
and consistent condom use on every occasion of sex is
diﬃcult. Interventions that convey knowledge and build
skills regarding STI/HIV can be eﬀective enough to prevent
new STI infections for as long as a year [51–53]. Given the
importance of motivations for women’s choice of method
described above, interventions that stress the prevalence and
seriousness of HIV and other STI may be a useful adjunct to
routine contraceptive counseling.
Concerns about unintended pregnancy, regardless of
contraceptive method used, are further mitigated by the
widespread availability, without prescription, of emergency
contraception(EC)[54].Lawsandpoliciesrelatedtoaccessi-
bilityvarysomewhatbystate[55].Emergencycontraceptives
workbypreventingovulationorfertilization,andpossiblyby
preventing implantation of the fertilized egg, although this
mechanism has not been supported by clinical data [55]. It
has been reported that the contraceptive strategy of condom
use with EC backup is increasing in prevalence since EC
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5. Interventions to Promote Dual Methods Use
Asmallnumberofbehavioralinterventionstoincreaseuseof
dual methods have been tested. One trial [57], randomized
black and Latina adolescent girls on HC either to a video,
STI/HIV counseling based on Project RESPECT [52], both
the video and counseling, or usual care. The video was
designed to promote dual methods and increase perceived
vulnerabilitytoHIV.Atathree-monthfollow-up,thewomen
who had received both interventions were signiﬁcantly more
likely to report having used a condom during their most
recent sexual encounter, compared with each of the other
three groups. Unfortunately, this result was nonsigniﬁcant
at the 12-month follow-up. This study suﬀered from severe
attrition, with only 55% of participants returning for the
three-month follow-up and 49% for the 12-month follow-
up. This low-retention rate renders interpretation of the
ﬁndings diﬃcult.
An analysis of data from the Project RESPECT trial, a
condom-focused multisite intervention study conducted in
STI clinics, examined uptake of condoms by women in the
trialwhowereusingHC[58].Amongthese women,condom
use increased as a result of the intervention, and most
women remained on their HC regimens. Thus, in response
to a condom-focused intervention, many women became
dual-methods users, although most did not use condoms
consistently (i.e., were alternating dual method users).
A more recent study tested a computer-based interven-
tion designed to encourage dual methods use among at-risk
women [59].Participants wereat risk foreither pregnancy or
STI and were enrolled irrespective of type of contraception
used. Women were randomized to receive this intervention
or general contraceptive information. Based on self-report,
the intervention increased the ever-use of dual methods.
While the conﬁdence interval of the unadjusted OR (1.38)
contained 1.00, when adjusted for baseline diﬀerences using
a propensity score, this eﬀect became signiﬁcant (although
alternating versus simultaneous use was not assessed).
Diﬀerences between treatment arms for consistent condom
use, STI, unplanned pregnancy, and individual STIs were
all nonsigniﬁcant. The authors interpreted these ﬁndings to
suggest that the use of dual methods was not sustained long
enough to prevent STI and pregnancy. Use of dual methods
was predicted by higher education level, substance use, and
u s eo fe i t h e rh o r m o n a lc o n t r a c e p t i v e so rm a l ec o n d o m sa t
baseline.
Finally, a recent study tested a provider-delivered inter-
vention designed to promote dual method use by providing
counseling both about STI risk and pregnancy risk, com-
pared with a standard of care in which only pregnancy
was addressed [60]. In both conditions, patients chose their
preferred method without speciﬁc encouragement from the
counselor. The primary outcome, rather than use of dual
methods per se, was the number of sex acts unprotected by
a male or female condom. The intervention group reported
3 fewer unprotected acts than the standard of care group, a
diﬀerence that approached signiﬁcance.
In summary, the research on interventions to promote
dual-method use is mixed. Condom-focused interventions
that focus attention on the threats of HIV and STI are
successful in increasing condom use, even when women are
on HC prior to the intervention. Other studies have yielded
mixed results—that is, self-reported outcomes at odds with
biological ones—and nonsustained or null results. These
results suggest that dual methods counseling frequently fails
to achieve its desired outcome, consistent and sustained
use of HC and condoms at every act of intercourse. Since
condoms protect very well against STI, and quite well against
pregnancy, and given the availability of EC should condom
failure occur, recommending consistent use of condoms may
be more eﬀective at preventing STI than recommending
the use of dual methods. Moreover, if the method used
must protect against the outcome of greatest concern for the
woman, and if that outcome is pregnancy, she may be less
tempted to abandon condom use if that is her only source
of protection. On the other hand, if she is protected from
pregnancy by hormonal contraceptives, she may be more
tempted to forego condoms, particularly under male resis-
tance.However,Ibelievethatthishypothesisshouldbetested
empirically, by comparing a dual-use recommendation with
a condom-only one. I would hypothesize that women in the
condom-only arm would acquire fewer STIs, but may need
t ou s eE Cm o r eo f t e na n dm a ye v e nb e c o m ep r e g n a n tm o r e
often. In addition, characteristics of successful dual-method
users could be identiﬁed, in a message-controlled context.
Would such a trial be feasible? Would young women be
willing to be randomized to the form of protection that they
would use for a prolonged period? Recent evidence suggests
that the answer to this question is “yes.” A feasibility study to
assesstheacceptabilityofanRCTtoexaminewhethertheuse
ofhormonalcontraceptivescreatesbiologicalvulnerabilityto
STIs has been conducted [61]. In this study, potential at-risk
participants were asked whether they would be willing to be
randomized to hormonal contraceptives or to an IUD. They
were also asked to provide urine or endocervical swabs for
STI testing. Overall, about 70% of participants said that they
would be willing to participate in this trial, indicating that
women are willing to be randomized, and suggesting that
such a trial is indeed feasible.
Would such a trial be ethical? Of course, informed
consent would be obtained, and participants will understand
that they can cease participation in the trial (or switch
arms?) without consequence. To ensure that participants
(and parents/guardians?) were fully informed and willing to
be randomized to either intervention, investigators would
explain to participants the advantages and disadvantages of
condoms and HC as tools for pregnancy and STI prevention.
The ethical sticking point appears to be, for some,
randomizing participants to receive a less eﬀective method
of contraception. However, the overall risks and beneﬁts to
study participants must be weighed to determine whether
equipoise exists between study arms. On the one hand,
the literature indicates that the condoms-only group would
receivealesseﬀectivepregnancypreventionmessagethanthe
dual-method (standard of care) arm. Therefore the apparent
risk of unintended pregnancy would be increased in the
condoms-only arm. But on the other hand, the condoms-
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message for preventing STIs, including HIV. (Could be
noted here or elsewhere the negative health consequences
of STI acquisition among teenagers.) The potential beneﬁt
of STI avoidance could balance or outweigh the increased
risk of failed contraception. Moreover, participants would
be counseled on emergency contraceptive use and given
access to this method in cases of failed contraception. This
counseling and access would reduce the risk of unintended
pregnancy among all study participants and mitigate the
increased risk in the condoms-only arm. Although the
recommendation to adolescents and young women at risk
for unplanned pregnancy and STI is to use both a hormonal
contraceptive to prevent pregnancy and male condoms to
prevent STI, there is evidence to suggest that this approach is
failing,andifthisisso,thatasigniﬁcant,unnecessaryburden
of STI, including HIV, may be the result. This hypothesis
should be tested empirically, using a rigorous design.
6. Looking to the Future:
DualProtectionTechnologies
It is possible that this issue will be solved by the development
of technologies that prevent both pregnancy and STI. The
global ﬁght against HIV has led to great eﬀorts to develop
topical microbicides that can be applied vaginally to neutral-
ize the virus before it can infect the woman. The premise
for the importance of such products was that, since men
control condom use and often may not agree to their use,
women needed methods to prevent STI/HIV infection that
were under their own control and undetectable by partners.
The ﬁrst such candidate was in fact a spermicidal surfactant,
nonoxynol-9, which was shown to kill HIV and other
sexually transmitted pathogens in vitro. Unfortunately, this
product caused in vivo damage to the epithelium, permitting
the entrance of HIV, and actually increased the likelihood
of infection with the virus [62]. A more recent attempt to
create a dual-method product, an acid-buﬀering gel, showed
promise as dual-protection agent [63] but unfortunately was
shown to be ineﬀective against HIV.
Eﬀorts to develop an eﬀective microbicide have contin-
ued, and currently focus on antiretroviral products [64].
Recently, the CAPRISA trial of a vaginal gel containing the
antiviral tenofovir was shown to reduce HIV incidence by
between 38% and 54%, depending on adherence, compared
to a placebo [65]. This product does not prevent pregnancy;
in fact a pregnancy rate of 4.0 per 100 women-year was
observed. Currently, most products in trials are ones that are
hoped to enable pregnancy, and are thus not dual-protection
agents. However, if an eﬀective microbicide is identiﬁed,
eﬀorts to create one that also prevents pregnancy will be the
next step [66].
7. Conclusion
Until fully eﬀective dual-protection technologies become
available, we will continue to face the conundrum of the
dual-method message. Should the recommended trial yield
the hypothesized results, an argument could be made for
recommending condom-only contraception, and the study
results could be informative as to the characteristics of
successful dual-method users.
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